| Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer | Clinical cancer research |  | | 2016 | 550 | 4 |
|
| Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features | Annals of oncology | | | 2014 | 679 | 0 |
|
| Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer | Journal of pathology |  | | 2013 | 609 | 1,747 |
|
| Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer | Journal of the National Cancer Institute | | | 2012 | 605 | 714 |
|
| Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial | Journal of clinical oncology | | | 2010 | 602 | 0 |
|
| Tissue biomarker development in a multicentre trial context: a feasibility study on the PETACC3 stage II and III colon cancer adjuvant treatment trial | Clinical cancer research | | | 2009 | 582 | 0 |
|
